IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Mabvax Therapeutics Hldgs in

CUSIP: 55414P702 | 18 institutional holders

Quarters

Q3 2022Q2 2022Q4 2021Q3 2021Q2 2019
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q3 2022

Eagle Bay Advisors LLC23
0.0% of portfolio›$0
StyleTurnoverLocationFiled
Eagle Bay Advisors LLC
23$00.0%GrowthMediumNew York, NY2022-11-23